Physician profile
Jeanine Devlin
NPI 1356343354
$1,808.56
in general payments reported to CMS, 2019-2025
17 companies · $580 in 2025
The $580 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $60.78 · 2022: $17.76 · 2023: $362 · 2024: $503 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $314.59 | 2024-2025 | |
| Abbvie INC. | $229.62 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $219.64 | 2020-2025 | Veozah |
| Exeltis, USA INC. | $207.20 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $167.94 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $139.55 | 2023-2025 | |
| Sage Therapeutics, LLC | $133.43 | 2023-2025 | Zurzuvae |
| Coopersurgical, INC. | $66.67 | 2019-2025 | Paragard T 380a |
| Avion Pharmaceuticals | $50.74 | 2019-2023 | Balcoltra |
| Vertical Pharmaceuticals, LLC | $49.57 | 2019 | |
| Therapeuticsmd, INC. | $47.65 | 2019-2022 | |
| Hologic Sales and Service, LLC | $45.63 | 2024-2025 | Aptima, Thinprep 2000 Processor, Fluent Fluid Management System |
| Pfizer INC. | $45.62 | 2019-2023 | |
| Millicent US INC | $40.84 | 2019-2025 | Intrarosa, Femlyv |
| Mylan Pharmaceuticals INC. | $17.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.49 | 2025 | Prolia, Evenity |
| Covidien Lp | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanine Devlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.